FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385778753> ?p ?o ?g. }

• W4385778753 endingPage "17923" @default.
• W4385778753 startingPage "17914" @default.
• W4385778753 abstract "Abstract Background This retrospective cohort study used an electronic health record‐derived, de‐identified, US patient‐level database to better understand the real‐world treatment experience, in a predominantly community setting (80.3% of patients), of venetoclax+hypomethylating agents (HMAs) in routine clinical care, pre‐ and post‐VIALE‐A, to determine whether the post‐remission cytopenia management insight from VIALE‐A was reflected in real‐world clinical practice. Methods Patients with newly diagnosed acute myeloid leukemia (AML; N = 498), who initiated venetoclax+HMA ≤30 days from AML diagnosis from June 1, 2018, to March 31, 2021, were stratified into pre‐( n = 330) and post‐( n = 168) VIALE‐A cohorts. Results More patients in the post‐(61%) versus pre‐(45%) VIALE‐A cohort had their first biopsy by 28 ± 14 days post‐treatment initiation. Patients underwent bone marrow (BM) assessment earlier in the post‐ versus pre‐VIALE‐A cohort, and first identification of response was also earlier (2.5 vs 5.1 months, respectively). More venetoclax schedule modifications post‐remission occurred among post‐(82.1%) versus pre‐(73.8%) VIALE‐A responders; the most common reason for modification was treatment toxicities, specifically cytopenia. Treatment survival outcomes were comparable with or without venetoclax schedule modifications. Conclusions Findings suggest that venetoclax schedule modifications can be used to manage cytopenia events without adversely affecting outcomes. Opportunities remain to improve earlier BM assessment to determine venetoclax schedule modifications, providing the best chance for optimal treatment outcomes." @default.
• W4385778753 created "2023-08-13" @default.
• W4385778753 creator A5001676777 @default.
• W4385778753 creator A5016360316 @default.
• W4385778753 creator A5027550311 @default.
• W4385778753 creator A5027772354 @default.
• W4385778753 creator A5038004259 @default.
• W4385778753 creator A5039196551 @default.
• W4385778753 creator A5046710013 @default.
• W4385778753 creator A5054058041 @default.
• W4385778753 creator A5058564945 @default.
• W4385778753 creator A5070962072 @default.
• W4385778753 date "2023-08-11" @default.
• W4385778753 modified "2023-10-17" @default.
• W4385778753 title "Post‐remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre‐ versus post‐VIALE‐A real‐world experience from a predominantly US community setting" @default.
• W4385778753 cites W1993449596 @default.
• W4385778753 cites W2559537906 @default.
• W4385778753 cites W2783500974 @default.
• W4385778753 cites W2809756112 @default.
• W4385778753 cites W2903407606 @default.
• W4385778753 cites W2980911308 @default.
• W4385778753 cites W2991619365 @default.
• W4385778753 cites W3011119029 @default.
• W4385778753 cites W3048827006 @default.
• W4385778753 cites W3097974232 @default.
• W4385778753 cites W3211710841 @default.
• W4385778753 cites W4289779105 @default.
• W4385778753 cites W4293581884 @default.
• W4385778753 cites W4385778753 @default.
• W4385778753 doi "https://doi.org/10.1002/cam4.6430" @default.
• W4385778753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37568276" @default.
• W4385778753 hasPublicationYear "2023" @default.
• W4385778753 type Work @default.
• W4385778753 citedByCount "1" @default.
• W4385778753 crossrefType "journal-article" @default.
• W4385778753 hasAuthorship W4385778753A5001676777 @default.
• W4385778753 hasAuthorship W4385778753A5016360316 @default.
• W4385778753 hasAuthorship W4385778753A5027550311 @default.
• W4385778753 hasAuthorship W4385778753A5027772354 @default.
• W4385778753 hasAuthorship W4385778753A5038004259 @default.
• W4385778753 hasAuthorship W4385778753A5039196551 @default.
• W4385778753 hasAuthorship W4385778753A5046710013 @default.
• W4385778753 hasAuthorship W4385778753A5054058041 @default.
• W4385778753 hasAuthorship W4385778753A5058564945 @default.
• W4385778753 hasAuthorship W4385778753A5070962072 @default.
• W4385778753 hasBestOaLocation W43857787531 @default.
• W4385778753 hasConcept C104317684 @default.
• W4385778753 hasConcept C126322002 @default.
• W4385778753 hasConcept C143998085 @default.
• W4385778753 hasConcept C150194340 @default.
• W4385778753 hasConcept C167135981 @default.
• W4385778753 hasConcept C185592680 @default.
• W4385778753 hasConcept C187212893 @default.
• W4385778753 hasConcept C190727270 @default.
• W4385778753 hasConcept C2776012956 @default.
• W4385778753 hasConcept C2777938653 @default.
• W4385778753 hasConcept C2778461978 @default.
• W4385778753 hasConcept C2779675984 @default.
• W4385778753 hasConcept C2780007613 @default.
• W4385778753 hasConcept C2780366003 @default.
• W4385778753 hasConcept C55493867 @default.
• W4385778753 hasConcept C71924100 @default.
• W4385778753 hasConcept C72563966 @default.
• W4385778753 hasConceptScore W4385778753C104317684 @default.
• W4385778753 hasConceptScore W4385778753C126322002 @default.
• W4385778753 hasConceptScore W4385778753C143998085 @default.
• W4385778753 hasConceptScore W4385778753C150194340 @default.
• W4385778753 hasConceptScore W4385778753C167135981 @default.
• W4385778753 hasConceptScore W4385778753C185592680 @default.
• W4385778753 hasConceptScore W4385778753C187212893 @default.
• W4385778753 hasConceptScore W4385778753C190727270 @default.
• W4385778753 hasConceptScore W4385778753C2776012956 @default.
• W4385778753 hasConceptScore W4385778753C2777938653 @default.
• W4385778753 hasConceptScore W4385778753C2778461978 @default.
• W4385778753 hasConceptScore W4385778753C2779675984 @default.
• W4385778753 hasConceptScore W4385778753C2780007613 @default.
• W4385778753 hasConceptScore W4385778753C2780366003 @default.
• W4385778753 hasConceptScore W4385778753C55493867 @default.
• W4385778753 hasConceptScore W4385778753C71924100 @default.
• W4385778753 hasConceptScore W4385778753C72563966 @default.
• W4385778753 hasIssue "17" @default.
• W4385778753 hasLocation W43857787531 @default.
• W4385778753 hasLocation W43857787532 @default.
• W4385778753 hasLocation W43857787533 @default.
• W4385778753 hasOpenAccess W4385778753 @default.
• W4385778753 hasPrimaryLocation W43857787531 @default.
• W4385778753 hasRelatedWork W2980911308 @default.
• W4385778753 hasRelatedWork W3033696780 @default.
• W4385778753 hasRelatedWork W3048827006 @default.
• W4385778753 hasRelatedWork W3063448455 @default.
• W4385778753 hasRelatedWork W4223544063 @default.
• W4385778753 hasRelatedWork W4295907640 @default.
• W4385778753 hasRelatedWork W4297905661 @default.
• W4385778753 hasRelatedWork W4310107633 @default.
• W4385778753 hasRelatedWork W4310127366 @default.
• W4385778753 hasRelatedWork W4322758439 @default.
• W4385778753 hasVolume "12" @default.
• W4385778753 isParatext "false" @default.

• next